CERT241220P12500
- 1.95
- 0.000.00%
Certara Newsroom
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3
Express News | Certara Inc : Jefferies Cuts Target Price to $12.50 From $15.50
Capital Allocation Trends At Certara (NASDAQ:CERT) Aren't Ideal
Baird Maintains Certara(CERT.US) With Hold Rating, Maintains Target Price $13
Certara Hold Rating Maintained Amid Mixed Performance and Regulatory Concerns
Forecasting The Future: 4 Analyst Projections For Certara
Q3 2024 Certara Inc Earnings Call
Certara Is Maintained at Equal-Weight by Barclays
Barclays Maintains Certara(CERT.US) With Hold Rating, Cuts Target Price to $12
JMP Securities Maintains Certara(CERT.US) With Hold Rating
JMP Securities Sticks to Their Hold Rating for Certara (CERT)
Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript Summary
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
Certara Non-GAAP EPS of $0.13 Beats by $0.02, Revenue of $94.8M Misses by $0.77M
Certara | 10-Q: Q3 2024 Earnings Report
Earnings Flash (CERT) CERTARA Posts Q3 Revenue $94.8M
Earnings Flash (CERT) CERTARA Posts Q3 EPS $0.13
Certara Sees FY24 EPS $0.41-$0.44 Vs $0.41 Est.; Revenue $380M-$385M Vs $386.5M Est.
Express News | Certara Reports Third Quarter 2024 Financial Results
Express News | Certara Q3 EPS USD -0.01